Suppr超能文献

移植植入前基因诊断结果不确定的胚胎:伦理意义。

Transferring embryos with indeterminate PGD results: the ethical implications.

作者信息

Insogna Iris G, Ginsburg Elizabeth

机构信息

Department of Obstetrics & Gynecology, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115 USA.

Department of Reproductive, Endocrinology and Infertility, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115 USA.

出版信息

Fertil Res Pract. 2016 Feb 1;2:2. doi: 10.1186/s40738-016-0014-9. eCollection 2016.

Abstract

BACKGROUND

In vitro fertilization (IVF) and pre-implantation genetic diagnosis (PGD) are becoming increasingly common techniques to select embryos that are unaffected by a known genetic disorder. Though IVF-PGD has high success rates, 7.5 % of blastocysts have inconclusive results after testing. A recent case involving a known BRCA-1 carrier was brought before our Assisted Reproductive Technology Ethics Committee in order to gain a better appreciation for the ethical implications surrounding the transfer of embryos with indeterminate testing.

THE CASE PRESENTATION

Thirty-nine year old G0 BRCA-1 carrier requiring IVF for male factor infertility. The couple elected for PGD to select against BRCA-1 gene carrier embryos. However, several embryos were returned with inconclusive results. The couple wished to proceed with the transfer of embryos with an unknown carrier status. The case was presented before our Assisted Reproductive Technology Ethics Committee.

CONCLUSION

Many considerations were explored, including the physician's duty to protect patient autonomy, the physician's duty to act in the best interest of the future child, and the physician's duty towards society. Transferring both embryos with unknown carrier status and known-carrier status was debated. Ultimately, the transfer of inconclusive embryos was felt to be ethically permissible in most cases if patients had been adequately counseled. However, the re-biopsy of embryos with inconclusive testing results was encouraged. The transfer of known-carrier embryos was felt to be unethical for certain disease-states, depending on the severity of illness and timing of disease onset. We strongly encourage physicians to create an action plan in advance with their patients, prior to testing, in the event that embryos are returned with inconclusive PGD results. The committee's decision, though helpful in guiding practice, should not overshadow the individual physician-patient relationship, and the need for thorough counseling.

摘要

背景

体外受精(IVF)和植入前基因诊断(PGD)正日益成为筛选不受已知遗传疾病影响的胚胎的常用技术。尽管IVF-PGD成功率很高,但7.5%的囊胚检测后结果不明确。最近,一个涉及已知BRCA-1基因携带者的案例提交到了我们的辅助生殖技术伦理委员会,以便更好地理解围绕移植检测结果不确定的胚胎所涉及的伦理问题。

病例介绍

一名39岁的G0期BRCA-1基因携带者,因男方因素不孕需要进行IVF。这对夫妇选择PGD以筛选出不携带BRCA-1基因的胚胎。然而,有几个胚胎检测结果不明确。这对夫妇希望移植携带状态未知的胚胎。该病例提交到了我们的辅助生殖技术伦理委员会。

结论

探讨了许多因素,包括医生保护患者自主权的责任、医生为未来孩子的最大利益行事的责任以及医生对社会的责任。对于移植携带状态未知和已知携带状态的胚胎都进行了讨论。最终,如果对患者进行了充分的咨询,大多数情况下移植检测结果不明确的胚胎在伦理上被认为是允许的。然而,鼓励对检测结果不明确的胚胎进行再次活检。对于某些疾病状态,根据疾病的严重程度和发病时间,移植已知携带基因的胚胎被认为是不道德的。我们强烈鼓励医生在检测前与患者提前制定一个行动计划,以防PGD结果不明确时出现胚胎。委员会的决定虽然有助于指导实践,但不应掩盖医生与患者的个体关系以及进行全面咨询的必要性。

相似文献

3
Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series.冷冻囊胚滋养层活检的结局:病例系列。
Reprod Biomed Online. 2012 Nov;25(5):504-7. doi: 10.1016/j.rbmo.2012.06.021. Epub 2012 Jul 20.

本文引用的文献

8
Genetic predisposition syndromes and their management.遗传易患综合征及其管理。
Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11.
9
The ESHRE PGD Consortium: 10 years of data collection.ESHRE PGD 联盟:10 年的数据收集。
Hum Reprod Update. 2012 May-Jun;18(3):234-47. doi: 10.1093/humupd/dmr052. Epub 2012 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验